[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363360-105":59,"doc-detail-363360-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","intensity-modulated-radiotherapyvolumetric-modulated-arc-therapy-including-four-brachytherapy-fractions-versus-3d-conformal-radiotherapy-containing-five-brachytherapy-fractions-in-the-treatment-of-cervical-cancer","Intensity-modulated radiotherapy/Volumetric modulated Arc therapy including four Brachytherapy fractions versus 3D conformal radiotherapy containing five Brachytherapy fractions in the treatment of cervical cancer","","Definitive radiochemotherapy using external beam radiotherapy plus brachytherapy is standard for locally advanced cervical cancer. This study retrospectively compares two institutional treatment pathways from different time periods: 3DCRT with five brachytherapy fractions and IMRT/VMAT with four brachytherapy fractions, both with concurrent chemotherapy. Outcomes include treatment duration, residual tumor, progression-free survival, overall survival, and toxicity, using dosimetric and histopathological assessment of response.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/intensity-modulated-radiotherapyvolumetric-modulated-arc-therapy-including-four-brachytherapy-fractions-versus-3d-conformal-radiotherapy-containing-five-brachytherapy-fractions-in-the-treatment-of-cervical-cancer/363360/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/intensity-modulated-radiotherapyvolumetric-modulated-arc-therapy-including-four-brachytherapy-fractions-versus-3d-conformal-radiotherapy-containing-five-brachytherapy-fractions-in-the-treatment-of-cervical-cancer/363360.png","ImageObject",300,407,{"name":92,"@type":93},"eBook King","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What treatment strategies are compared in this study?","Question",{"text":112,"@type":113},"The study compares 3DCRT with five brachytherapy fractions versus IMRT/VMAT with four brachytherapy fractions, both delivered with concurrent chemotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which endpoints were used to evaluate effectiveness and safety?",{"text":117,"@type":113},"Endpoints include treatment duration, residual tumor, progression-free survival (PFS), overall survival (OS), and toxicity, supported by dosimetric and histopathological evaluations.",{"name":119,"@type":110,"acceptedAnswer":120},"Were there significant differences in progression-free survival and overall survival?",{"text":121,"@type":113},"After a median 60-month follow-up, no statistically significant differences were found in PFS or OS between the two pathways.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363360,1790212102,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Feroz etal. Radiation Oncology (2026) 21:68 [https://doi.org/10.1186/s13014-026-02834-9](https://doi.org/10.1186/s13014-026-02834-9)  \nRadiation Oncology  \nRESEARCH Open Access  \nIntensity-modulated radiotherapy/Volumetric  modulated Arc therapy including four Brachytherapy fractions versus 3D conformal radiotherapy containing five Brachytherapy fractions in the treatment of cervical cancer  \nBarin Feroz 1†, Christoph Ebner 1, Sergej Skvortsov2, Ricarda Purtscheller 1, Katharina Steger1,  \nMagdalena Steinlechner1, Miriam Emmelheinz 1, Jana Rieker 1, Katharina Leitner 1, Ute Ganswindt2, Sarah Maier3, Christian Marth 1 and Alain Gustave Zeimet1*  \nAbstract  \nBackground Definitive radiochemotherapy with external beam radiotherapy and brachytherapy is standard for locally advanced cervical cancer (LACC) . Advanced techniques like intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) have replaced 3D-conformal radiotherapy (3DCRT) . This study compares two institutional definitive radiotherapy treatment pathways implemented in different time periods: 3DCRT with five BT fractions and IMRT/VMAT with four BT fractions.  \nMethods This retrospective single-center study included 145 patients with FIGO 2018 stage IB3–IVA LACC treated during 2008–2023. Patients received 3DCRT+5BT (2008–2016; n = 77) or IMRT/VMAT+4BT (2017–2023; n = 68) with concurrent chemotherapy. Histopathological biopsies at final BT evaluated tumor response. Dosimetric parameters (HRCTV-D90–EQD2₍₁₀₎ and OAR-D2cc for bladder, rectum, sigmoid) were analyzed. Endpoints included treatment duration, residual tumor, progression-free survival (PFS), overall survival (OS), and toxicity.  \nResults After a median follow-up of 60 months, no significant differences were seen in PFS (HR 0 . 68, 95% CI 0.34– 1. 38, p = 0 . 285) or OS (HR 0 .47, 95% CI 0 .17–1. 29, p = 0 . 133) . Histologically confirmed residual tumor rates were 22. 1%(IMRT/VMAT+4BT) vs. 31. 2%(3DCRT+5BT; p= 0 . 262) . IMRT/VMAT+4BT patients more often completed therapy within 49 days (63 . 2% vs. 20. 8%; p \u003C 0. 001) . Median HRCTV D90 EQD2₍₁₀₎ was 85.3 Gy vs. 76.5 Gy (p \u003C 0. 001) in favor of IMRT/ VMAT, while OAR doses remained within limits. IMRT/VMAT showed significantly fewer gastrointestinal, genitourinary, skin, and mucosal toxicities (all p \u003C 0. 05) and less systemic deterioration.  \n†Barin Feroz is the first author for this article.  \n*Correspondence:  \nAlain Gustave Zeimet[alain.zeimet@i-med.ac.at](alain.zeimet@i-med.ac.at)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nFeroz et al. Radiation Oncology (2026) 21:68 Page 2 of 11  \nConclusion In this era-based single-institution comparison of two treatment pathways, IMRT/VMAT+4BT achieved numerically better oncologic outcomes without reaching statistical significance. IMRT/V","cbCaivgEokMmpOud","https://ap.wps.com/l/cbCaivgEokMmpOud","pdf",1577709,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Standard of care and evolving EBRT techniques\n## Imaging-guided adaptive brachytherapy and clinical trials","[{\"question\":\"What treatment strategies are compared in this study?\",\"answer\":\"The study compares 3DCRT with five brachytherapy fractions versus IMRT/VMAT with four brachytherapy fractions, both delivered with concurrent chemotherapy.\"},{\"question\":\"Which endpoints were used to evaluate effectiveness and safety?\",\"answer\":\"Endpoints include treatment duration, residual tumor, progression-free survival (PFS), overall survival (OS), and toxicity, supported by dosimetric and histopathological evaluations.\"},{\"question\":\"Were there significant differences in progression-free survival and overall survival?\",\"answer\":\"After a median 60-month follow-up, no statistically significant differences were found in PFS or OS between the two pathways.\"}]","Intensity-modulated radiotherapy/Volumetric modulated Arc therapy including four Brachytherapy fractions versus 3D conformal radiotherapy containing five Brachytherapy fractions in the treatment of cervical cancer | PDF",1790150935,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e6f1ff98c8641e5aaaa6968fcda45309.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f73f1891b2db4fbcfc847916090a3de.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7aca6efc3e159e778642f9a141db81f0.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6c13cfcdffce88b8b5746765a53cfc6.webp",980,1306]